Albert David Ltd Stock Price Today (NSE: ALBERTDAVD)
Fundamental Score
Albert David Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Albert David Ltd share price today is ₹741.95, up +0.00% on NSE/BSE as of 18 February 2026. Albert David Ltd (ALBERTDAVD) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹444.56 (Cr). The 52-week high for ALBERTDAVD share price is ₹N/A and the 52-week low is ₹N/A. The company has a Return on Equity (ROE) of 4.39% and a debt-to-equity ratio of 0.11.
Albert David Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Albert David Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Albert David Share Price Analysis: A ROCE Efficiency Perspective
The pharmaceutical industry is currently undergoing a period of intense margin pressure, driven by generic competition and increasing regulatory scrutiny. Companies with efficient capital allocation are best positioned to navigate this challenging environment. This analysis examines Albert David share price, currently at ₹680.549988, through the lens of Return on Capital Employed (ROCE) to gauge its operational effectiveness. The company's ROCE currently stands at 6.45%, a key metric reflecting how well the company is utilizing its capital to generate profits.
A ROCE of 6.45% warrants careful consideration. While ROCE isn't the only factor, it influences long-term sustainability. Albert David's lack of a listed Price-to-Earnings (PE) ratio suggests either losses or exceptionally volatile earnings, making ROCE an even more crucial indicator. A low ROCE compared to the cost of capital may indicate a lack of economic moat. This impacts the company's ability to fend off competition and maintain profitability over the long term. Improvement in efficiency would likely improve Albert David's financial standing.
Comparing Albert David Ltd to its peers provides further context. For instance,
Mankind Pharma Ltd generally commands a higher valuation, potentially reflecting investor confidence in its management team’s ability to effectively deploy capital and generate superior returns. While we don't have ROCE data for Smruthi Organics Ltd and Balaxi Pharmaceuticals Ltd here, benchmarking Albert David against companies with similar business models but higher ROCE could reveal opportunities for improvement in Albert David's operational strategies and resource allocation.Ultimately, a sustainable competitive advantage, or economic moat, is built on consistently generating returns above the cost of capital. Albert David's current ROCE level suggests limited moat strength. Improving this metric will be crucial for long-term shareholder value creation. This financial analysis is part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra. It is observational in nature and does not constitute investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Albert David Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ALBERTDAVD across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Conservative Debt Levels (D/E: 0.11)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Cash Generation (₹64.39 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (62.24%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
9 factors identified
Below-Average Return on Equity (4.39%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (6.45%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-118.26%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-11.38%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (1.52% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-2.13% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-2.13% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Weak Interest Coverage (-9.33x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Limited Institutional Interest (FII+DII: 2.25%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Albert David Ltd Financial Statements
Comprehensive financial data for Albert David Ltd including income statement, balance sheet and cash flow
About ALBERTDAVD (Albert David Ltd)
Albert David Ltd (ALBERTDAVD) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a current market capitalisation of ₹444.56 (Cr). Albert David Ltd has delivered a Return on Equity (ROE) of 4.39% and a ROCE of 6.45%. The debt-to-equity ratio stands at 0.11, reflecting the company's capital structure. Investors tracking ALBERTDAVD share price can monitor key metrics including P/E ratio, promoter holding of 62.24%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
ALBERTDAVD Share Price: Frequently Asked Questions
What is the current share price of Albert David Ltd (ALBERTDAVD)?
As of 18 Feb 2026, 07:19 am IST, Albert David Ltd share price is ₹741.95. The ALBERTDAVD stock has a market capitalisation of ₹444.56 (Cr) on NSE/BSE.
Is ALBERTDAVD share price Overvalued or Undervalued?
ALBERTDAVD share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 31.77x. Based on this relative valuation, the Albert David Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of ALBERTDAVD share price?
The 52-week high of ALBERTDAVD share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Albert David Ltd share price?
Key factors influencing ALBERTDAVD share price include quarterly earnings growth (Sales Growth: -11.38%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Albert David Ltd a good stock for long-term investment?
Albert David Ltd shows a 5-year Profit Growth of -2.13% and an ROE of 4.39%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.11 before investing in ALBERTDAVD shares.
How does Albert David Ltd compare with its industry peers?
Albert David Ltd competes with major peers in the Pharmaceuticals. Investors should compare ALBERTDAVD share price P/E of 0.00x and ROE of 4.39% against the industry averages to determine competitive standing.
What is the P/E ratio of ALBERTDAVD and what does it mean?
ALBERTDAVD share price has a P/E ratio of N/Ax compared to the industry average of 31.77x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is ALBERTDAVD performing according to Bull Run's analysis?
ALBERTDAVD has a Bull Run fundamental score of 18.6/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does ALBERTDAVD belong to?
ALBERTDAVD operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Albert David Ltd share price.
What is Return on Equity (ROE) and why is it important for ALBERTDAVD?
ALBERTDAVD has an ROE of 4.39%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Albert David Ltd generates profits from shareholders capital.
How is ALBERTDAVD debt-to-equity ratio and what does it indicate?
ALBERTDAVD has a debt-to-equity ratio of 0.11, which indicates conservative financing with low financial risk.
What is ALBERTDAVD dividend yield and is it a good dividend stock?
ALBERTDAVD offers a dividend yield of 0.64%, meaning you receive ₹0.64 annual dividend for every ₹100 invested in Albert David Ltd shares.
How has ALBERTDAVD share price grown over the past 5 years?
ALBERTDAVD has achieved 5-year growth rates of: Sales Growth 1.52%, Profit Growth -2.13%, and EPS Growth -2.13%.
What is the promoter holding in ALBERTDAVD and why does it matter?
Promoters hold 62.24% of ALBERTDAVD shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Albert David Ltd.
What is ALBERTDAVD market capitalisation category?
ALBERTDAVD has a market capitalisation of ₹445 crores, placing it in the Small-cap category.
How volatile is ALBERTDAVD stock?
ALBERTDAVD has a beta of N/A. A beta > 1 suggests the Albert David Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is ALBERTDAVD operating profit margin trend?
ALBERTDAVD has a 5-year average Operating Profit Margin (OPM) of 9.63%, indicating the company's operational efficiency.
How is ALBERTDAVD quarterly performance?
Recent quarterly performance shows Albert David Ltd YoY Sales Growth of -11.38% and YoY Profit Growth of -118.26%.
What is the institutional holding pattern in ALBERTDAVD?
ALBERTDAVD has FII holding of 0.60% and DII holding of 1.65%. Significant institutional holding often suggests professional confidence in the Albert David Ltd stock.